SEC FORM
4
SEC Form 4
FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0287 |
Estimated average burden |
hours per response: |
0.5 |
|
|
|
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b). |
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
AMICUS THERAPEUTICS INC
[ FOLD ]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/12/2008
|
4. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
1. Title of Security (Instr.
3)
|
2. Transaction Date
(Month/Day/Year) |
2A. Deemed Execution Date, if any
(Month/Day/Year) |
3. Transaction Code (Instr.
8)
|
4. Securities Acquired (A) or Disposed Of (D) (Instr.
3, 4 and 5)
|
5.
Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
7. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
Amount |
(A) or (D) |
Price |
Common Stock |
02/12/2008 |
|
P |
|
709 |
A |
$9.99
|
608,976 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
1,200 |
A |
$10
|
610,176 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
2,000 |
A |
$10.01
|
612,176 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
1,891 |
A |
$10.02
|
614,067 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
1,600 |
A |
$10.03
|
615,667 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
600 |
A |
$10.04
|
616,267 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
800 |
A |
$10.05
|
617,067 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
300 |
A |
$10.06
|
617,367 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
200 |
A |
$10.1
|
617,567 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/12/2008 |
|
P |
|
100 |
A |
$10.12
|
617,667 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
101 |
A |
$10.1
|
617,768 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
100 |
A |
$10.17
|
617,868 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
200 |
A |
$10.18
|
618,068 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
200 |
A |
$10.2
|
618,268 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
100 |
A |
$10.21
|
618,368 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
200 |
A |
$10.24
|
618,568 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
292 |
A |
$10.25
|
618,860 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
707 |
A |
$10.26
|
619,567 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
100 |
A |
$10.3
|
619,667 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
100 |
A |
$10.32
|
619,767 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
200 |
A |
$10.33
|
619,967 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
600 |
A |
$10.34
|
620,567 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
500 |
A |
$10.35
|
621,067 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
600 |
A |
$10.37
|
621,667 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
1,000 |
A |
$10.38
|
622,667 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
400 |
A |
$10.39
|
623,067 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
200 |
A |
$10.4
|
623,267 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
300 |
A |
$10.41
|
623,567 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
100 |
A |
$10.42
|
623,667 |
I |
By Frazier Healthcare V, LP
|
Common Stock |
02/13/2008 |
|
P |
|
200 |
A |
$10.43
|
623,867 |
I |
By Frazier Healthcare V, LP
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Transaction Date
(Month/Day/Year) |
3A. Deemed Execution Date, if any
(Month/Day/Year) |
4. Transaction Code (Instr.
8)
|
5.
Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
3, 4 and 5)
|
6. Date Exercisable and Expiration Date
(Month/Day/Year) |
7. Title and Amount of Securities Underlying Derivative Security (Instr.
3 and 4)
|
8. Price of Derivative Security (Instr.
5)
|
9.
Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
4)
|
10. Ownership Form: Direct (D) or Indirect (I) (Instr.
4)
|
11. Nature of Indirect Beneficial Ownership (Instr.
4)
|
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
1. Name and Address of Reporting Person*
601 UNION STREET, SUITE 3200 |
|
(Street)
|
Explanation of Responses: |
Remarks: |
|
FHM IV, LP, By: FHM IV, LLC, its General Partner, By: /s/ Thomas S. Hodge, Chief Operating
Officer |
02/14/2008 |
|
Frazier Healthcare V, LP, By: FHM V, LP, its General Partner, By: FHM V, LLC, its General Partner,
By: /s/ Thomas S. Hodge, Chief Operating Officer |
02/14/2008 |
|
FHM V, LP, By: FHM V, LLC, its General Partner, By: /s/ Thomas S. Hodge, Chief Operating
Officer |
02/14/2008 |
|
FHM V, LLC, By: /s/ Thomas S. Hodge, Chief Operating Officer |
02/14/2008 |
|
Frazier Healthcare IV, LP, By: FHM IV, LP, its General Partner, By: FHM IV, LLC, its General
Partner, By: /s/ Thomas S. Hodge, Chief Operating Officer |
02/14/2008 |
|
Frazier Affiliates IV, LP, By: FHM IV, LP, its General Partner, By: FHM IV, LLC, its General
Partner, By: /s/ Thomas S. Hodge, Chief Operating Officer |
02/14/2008 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
4
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Exhibit 99.1
Form 4 Joint Filer Information
Name: Frazier Healthcare V, LP
Address: 601 Union Street, Suite 3200, Seattle, WA 98101
Designated Filer: FHM IV, LP
Issuer & Ticker Symbol: Amicus Therapeutics, Inc. (FOLD)
Date of Event Requiring Statement: February 12, 2008
Frazier Healthcare V, LP
By: FHM V, LP, its General Partner
By: FHM V, LLC, its General Partner
By: /s/ Thomas S. Hodge
Thomas S. Hodge,
Chief Operating Officer
Name: FHM V, LP
Address: 601 Union Street, Suite 3200, Seattle, WA 98101
Designated Filer: FHM IV, LP
Issuer & Ticker Symbol: Amicus Therapeutics, Inc. (FOLD)
Date of Event Requiring Statement: February 12, 2008
FHM V, LP
By: FHM V, LLC, its General Partner
By: /s/ Thomas S. Hodge
Thomas S. Hodge,
Chief Operating Officer
Name: FHM V, LLC
Address: 601 Union Street, Suite 3200, Seattle, WA 98101
Designated Filer: FHM IV, LP
Issuer & Ticker Symbol: Amicus Therapeutics, Inc. (FOLD)
Date of Event Requiring Statement: February 12, 2008
FHM V, LLC
By: /s/ Thomas S. Hodge
Thomas S. Hodge,
Chief Operating Officer
Name: Frazier Healthcare IV, LP
Address: 601 Union Street, Suite 3200, Seattle, WA 98101
Designated Filer: FHM IV, LP
Issuer & Ticker Symbol: Amicus Therapeutics, Inc. (FOLD)
Date of Event Requiring Statement: February 12, 2008
Frazier Healthcare IV, LP
By: FHM IV, LP, its General Partner
By: FHM IV, LLC, its General Partner
By: /s/ Thomas S. Hodge
Thomas S. Hodge,
Chief Operating Officer
Name: Frazier Affiliates IV, LP
Address: 601 Union Street, Suite 3200, Seattle, WA 98101
Designated Filer: FHM IV, LP
Issuer & Ticker Symbol: Amicus Therapeutics, Inc. (FOLD)
Date of Event Requiring Statement: February 12, 2008
Frazier Affiliates IV, LP
By: FHM IV, LP, its General Partner
By: FHM IV, LLC, its General Partner
By: /s/ Thomas S. Hodge
Thomas S. Hodge,
Chief Operating Officer
Name: FHM IV, LP
Address: 601 Union Street, Suite 3200, Seattle, WA 98101
Designated Filer: FHM IV, LP
Issuer & Ticker Symbol: Amicus Therapeutics, Inc. (FOLD)
Date of Event Requiring Statement: February 12, 2008
FHM IV, LP
By: FHM IV, LLC, its General Partner
By: /s/ Thomas S. Hodge
Thomas S. Hodge,
Chief Operating Officer